- Home
- WYNN vs RVMD Comparison
WYNN vs RVMD Comparison
Compare WYNN & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYNN | RVMD |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 15.2B |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WYNN | RVMD |
|---|---|---|
| Price | $114.96 | $118.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $143.50 | $90.13 |
| AVG Volume (30 Days) | 1.1M | ★ 4.8M |
| Earning Date | 02-12-2026 | 02-25-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.59 | N/A |
| Revenue | ★ $7,110,738,000.00 | N/A |
| Revenue This Year | $2.05 | N/A |
| Revenue Next Year | $3.68 | $714.57 |
| P/E Ratio | $24.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.25 | $29.17 |
| 52 Week High | $134.72 | $124.49 |
Technical Indicators
Market Signals| Indicator | WYNN | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.31 | 77.17 |
| Support Level | $110.74 | $113.96 |
| Resistance Level | $118.22 | $124.49 |
| Average True Range (ATR) | 3.18 | 6.94 |
| MACD | -0.42 | 1.26 |
| Stochastic Oscillator | 33.46 | 88.66 |
Price Performance
Historical ComparisonAbout WYNN Wynn Resorts Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform, in a few states. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.